Key market opportunities in the shingles vaccine sector include rising elderly populations; expanding healthcare ...
Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to ...
Ginkgo Bioworks announced today that it has been awarded a contract through the Biomedical Advanced Research and Development Authority's (BARDA) Biopharmaceutical Manufacturing Preparedness Consortium ...
AI-powered vector design and preclinical validation mark the first step in a multi-phase program aimed at accelerating the path from discovery to clinical assessment in Alzheimer's disease. AUSTIN, TX ...
Prescient investors who participated in Immaterial’s £13.5million Series A2 funding round will be delighted that the advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results